Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma

作者: Joost J.C. Verhoeff , Lukas J.A. Stalpers , An Claes , Koos E. Hovinga , Gijsbert D. Musters

DOI: 10.1016/J.EJCA.2009.08.004

关键词: PegaptanibMedicineHypoxia (medical)RatónAngiogenesisCell cultureBlood vesselRadiation therapyGliomaPathologyCancer researchOncology

摘要: Aim of the study: Tumour angiogenesis and invasion are key features glioblastoma multiforme (GBM). Angiogenesis inhibitors increase progression-free survival (PFS) recurrent GBM patients. VEGF inhibition controls bulk tumour growth by angiogenesis, but does not inhibit invasive component. We investigated if can be controlled combining anti-VEGF treatment with irradiation plus surrounding brain in an orthotopic murine model for GBM. Methods materials: cell line U251-NG2 was inoculated through a guide screw right frontal lobe 53 athymic nude mice. Pegaptanib (a slow-releasing aptamer against VEGF) injected bed either or followed implanted I-125 seeds. and/or were compared sham-treated controls, resulting four groups 10-15 mice each. After 6 weeks treatment, histological analysis performed on all brains. Results: locally deposited pegaptanib decreased blood vessel density, increased hypoxia. still allowed formation satellites. Irradiation size suppressed Combined further PFS. directly correlated Concluding statement: The anti-tumour effects local partially circumvented Additional is effective slowing down proliferation these components.

参考文章(42)
Martha Chekenya, Mari Hjelstuen, Per Øyvind Enger, Frits Thorsen, Anne L. Jacob, Beatrice Probst, Olav Haraldseth, Geoffrey Pilkington, Arthur Butt, Joel M. Levine, Rolf Bjerkvig, NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin The FASEB Journal. ,vol. 16, pp. 586- 588 ,(2002) , 10.1096/FJ.01-0632FJE
Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham, Matthew Feinsod, David R. Guyer, Pegaptanib for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 351, pp. 2805- 2816 ,(2004) , 10.1056/NEJMOA042760
Ricky T. Tong, Yves Boucher, Sergey V. Kozin, Frank Winkler, Daniel J. Hicklin, Rakesh K. Jain, Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors Cancer Research. ,vol. 64, pp. 3731- 3736 ,(2004) , 10.1158/0008-5472.CAN-04-0074
KE Hovinga, LJA Stalpers, C Van Bree, M Donker, JJC Verhoeff, HM Rodermond, DA Bosch, WR Van Furth, None, Radiation-Enhanced Vascular Endothelial Growth Factor (VEGF) Secretion in Glioblastoma Multiforme Cell Lines – A Clue to Radioresistance? Journal of Neuro-oncology. ,vol. 74, pp. 99- 103 ,(2005) , 10.1007/S11060-004-4204-7
Jerry R. Williams, Yonggang Zhang, Haoming Zhou, Daila S. Gridley, Cameron J. Koch, James M. Slater, John B. Little, Overview of Radiosensitivity of Human Tumor Cells to Low-Dose-Rate Irradiation International Journal of Radiation Oncology Biology Physics. ,vol. 72, pp. 909- 917 ,(2008) , 10.1016/J.IJROBP.2008.06.1928
Ahlame Saidi, Martin Hagedorn, Nathalie Allain, Chiara Verpelli, Carlo Sala, Lorenzo Bello, Andreas Bikfalvi, Sophie Javerzat, Combined targeting of interleukin‐6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness International Journal of Cancer. ,vol. 125, pp. 1054- 1064 ,(2009) , 10.1002/IJC.24380
Omar M. Salazar, M.D. Philip Rubin, Michael L. Feldstein, Robert Pizzutiello, High dose radiation therapy in the treatment of malignant gliomas: Final Report International Journal of Radiation Oncology Biology Physics. ,vol. 5, pp. 1733- 1740 ,(1979) , 10.1016/0360-3016(79)90554-6
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen, Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology. ,vol. 72, pp. 779- 787 ,(2008) , 10.1212/01.WNL.0000304121.57857.38
James L. Rubenstein, Jin Kim, Tomoko Ozawa, Michael Zhang, Manfred Westphal, Dennis F. Deen, Marc A. Shuman, Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia. ,vol. 2, pp. 306- 314 ,(2000) , 10.1038/SJ.NEO.7900102